Evaluating Treatment Costs
Understanding the financial requirements for ketamine therapy in the New York City area is an essential step in planning your care. Off-label ketamine administration, which includes intravenous (IV), intramuscular (IM), or sublingual forms, is generally a self-pay service. Because it is not FDA-approved for psychiatric conditions, health insurance plans rarely cover the medication or the clinical observation time.
In contrast, Spravato (esketamine) is an FDA-approved nasal spray for specific adult depression indications. Depending on your health insurance policy, some or all of the medication and clinical monitoring costs may be covered. Securing this coverage typically requires a thorough prior authorization process, demonstrating that other conventional treatments have been tried without success.
Planning for Additional Expenses
Patients should always request a detailed, written estimate from their chosen clinic before beginning a treatment regimen. This estimate should clarify the costs of the initial psychiatric consultation, the medication itself, and the required in-office monitoring sessions. Additionally, residents of Brooklyn Heights should budget for transit costs, such as subway or taxi fares to Manhattan.
It is also important to consider the FDA warning about compounded ketamine products, which highlights potential risks associated with at-home use or unmonitored settings.